Jade Biosciences Secures $80 Million Funding to Advance Breakthrough Therapies for Autoimmune Diseases

Jade Biosciences, a biotechnology innovator focused on autoimmune diseases, has announced the successful closing of an $80 million financing round. Led by Fairmount and Venrock Healthcare Capital Partners, with additional contributions from Deep Track Capital, Driehaus Capital Management, Franklin Templeton, RTW Investments, and Braidwell LP, this investment will drive the development of Jade’s cutting-edge therapies…

Read More

Eric Stonestrom Appointed as Board Chair of Cox Science Center and Aquarium

The Cox Science Center and Aquarium (CSCA) proudly announces the appointment of Eric Stonestrom as its new Board Chair, effective immediately following the retirement of Lew Crampton. Stonestrom, a distinguished technology executive with a deep-rooted passion for sciences, brings over 40 years of expertise in telecommunications to his new role. “Eric’s appointment marks an exciting…

Read More

UK-based tem. Gains £10.5 Million in Series A Funding for AI-Driven Renewable Energy Platform

tem., an innovative AI-powered platform facilitating direct transactions between UK businesses and renewable energy generators, has successfully raised £10.5 million in Series A funding. This latest round of investment boosts the company’s total funding to £13 million, positioning it for significant expansion and impact in the renewable energy sector. The core of tem.’s platform is…

Read More

Graph AI Secures $3 Million Seed Funding to Revolutionize Pharmacovigilance with AI-Powered Automation

California-based Graph AI, a promising new entrant in the pharmacovigilance space, has raised $3 million in a seed funding round led by Bessemer Venture Partners. Founded in 2024, Graph AI is pioneering an AI-native platform designed to transform the cumbersome and error-prone process of adverse drug event (ADE) monitoring that pharmaceutical companies are mandated to…

Read More
TechWolf_team_Founders

TechWolf Secures $42.75M Series B Funding to Pioneer AI-Driven Talent Management Solutions

TechWolf, the Belgian innovator at the forefront of AI-powered talent management, has successfully concluded a Series B funding round, raising an impressive $42.75 million. This funding marks a pivotal moment for the company as it embarks on expanding its AI infrastructure dedicated to revolutionizing employee skills management. Founded in 2018 by Andreas De Neve, Jeroen…

Read More

Gradient AI Secures $56 Million in Series C Round to Drive Innovation in AI-Powered Insurance Solutions

Gradient AI, a premier enterprise software provider specializing in artificial intelligence for the insurance sector, has successfully closed a Series C funding round, securing $56.1 million. This substantial investment, spearheaded by Centana Growth Partners and supported by existing investors MassMutual Ventures, Sandbox Insurtech Ventures, and Forte Ventures, is poised to significantly bolster the company’s capabilities…

Read More

PayPal Ventures Expands Investment in Chaos Labs, Reinforcing Confidence in Onchain Risk Management

PayPal Ventures, the global venture capital arm of PayPal, has announced a significant additional investment in Chaos Labs, an emerging leader in onchain risk management. This move not only highlights PayPal’s faith in Chaos Labs’ innovative blockchain solutions but also underscores the growing importance of risk management in the rapidly evolving crypto landscape. Chaos Labs…

Read More

Family.cards Secures €1.2M Seed Funding to Enhance Digital Accessibility for Seniors

In a significant boost for digital inclusivity among seniors, Family.cards, a burgeoning healthtech startup, has announced the successful closure of a €1.2 million seed funding round. The investment was led by Brandenburg Kapital and OHA Osnabruck Healthcare 7 Ventures, with participation from existing backers, Antler and Birdhouse. Founded in 2022 by Teo Ortega and Simon…

Read More

PhoreMost Secures £33M in Series B Funding to Propel ‘Drugging the Undruggable’ Innovation

PhoreMost, the cutting-edge UK biopharmaceutical enterprise specializing in innovative drug development, has successfully closed an impressive £33 million Series B funding round. This latest round, which saw significant oversubscription, underscores the growing confidence in PhoreMost’s pioneering approach to addressing previously untargetable disease mechanisms. Central to PhoreMost’s strategy is their revolutionary SITESEEKER platform. This technology excels…

Read More